The research results were both promising and reassuring, Ramani said. Not only is intrapartum azithromycin safe for mothers, as previously confirmed by a clinical trial, but it also poses no risk of growth impairment or neurodevelopmental impairment in their children.
“It underscores the university’s growing influence in international health research and its commitment to improving outcomes for mothers and babies worldwide,” said Maran Ramani, M.D.
“This funding is a game-changer for revamping our neonatal abstinence syndrome program. With this grant, we will roll out the Eat, Sleep, Console care framework, a proven approach that dramatically reduces hospital days for neonates with opioid withdrawal syndrome without increasing adverse outcomes,” said Manimaran (Maran) Ramani, M.D.
Maran Ramani, M.D., was awarded a three-year grant from the Thrasher Research Fund in 2022 to conduct a multinational clinical study, known as the Azithromycin Brain neuroprotection for Children study.
USA Health will share its experiences in caring for 22-23 weekers with the rest of the world and gain knowledge from other centers that do the same.
USA Health expands leadership team with announcement of inaugural Chief Medical Officer for Children’s & Women’s Hospital.
A National Institutes of Health multisite study could lead to a consistent standard of care for antibiotic administration in NICUs.
Several hundred people attended the first NICU reunion since the start of the pandemic, to celebrate life and hope.
The NICU Reunion serves as a celebration of life and a reminder of hope for the caregivers “who were never willing to give up, even when the chances of progress were bleak.”
Ramani is board certified in general pediatrics and neonatal-perinatal medicine by the American Board of Pediatrics. He completed a fellowship in neonatology at UAB and a pediatric residency at Texas Tech Health Sciences Center in Lubbock, Texas.
